Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-30T01:48:35.582Z Has data issue: false hasContentIssue false

Chap 8 - FIBROMATOSES

Published online by Cambridge University Press:  01 March 2011

By
Markku Miettinen
Edited by
Markku Miettinen
Markku Miettinen
Affiliation:
Armed Forces Institute of Pathology, Washington DC
Get access

Summary

The designation fibromatosis refers to a specific group of locally recurring and potentially aggressive but nonmetastasizing fibroblastic and myofibroblastic tumors. These include palmar and plantar fibromatosis, which are often together referred to as superficial fibromatoses. Penile fibromatosis (Peyronie's disease) is often attached to this group, although it is not certain whether it is truly comparable with other fibromatoses.

Deep, fascia-associated or intramuscular fibromatoses are called desmoid tumors, synonymously known as aggressive fibromatoses and musculoaponeurotic fibromatoses. All fibromatoses are composed of fibroblasts with a substantial myofibroblastic component. General features and clonal chromosomal changes suggest that both superficial and deep fibromatoses are clonal, neoplastic processes. Although there have been misgivings about the continuing use of the term desmoid fibromatosis (or briefly, desmoid), the existence of different types of fibromatoses (especially in childhood) justifies this as a specifying designation.

Some fibromatoses, such juvenile fibromatosis and lipofibromatosis, occur exclusively in children. Several childhood conditions called fibromatosis are not true fibromatoses, but reactive processes (fibromatosis colli), peculiar hyperplastic processes (gingival fibromatosis), or aberrations in morphogenesis (juvenile hyaline fibromatosis). These childhood lesions termed fibromatoses are discussed in Chapter 9.

PALMAR AND PLANTAR FIBROMATOSIS

Clinical Features

Palmar fibromatosis is also known as Dupuytren's contracture, named after an early nineteenth-century French surgeon who described this condition. Palmar fibromatosis is common especially in men of northern and eastern European, Scottish, and Irish descent.

Type
Chapter
Information
Modern Soft Tissue Pathology
Tumors and Non-Neoplastic Conditions
 , pp. 238 - 254
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ross, DC. Epidemiology of Dupuytren's disease. Hand Clin 1999;15:53–62.Google ScholarPubMed
Gudmundsson, KG, Arngrimsson, R, Sigfusson, N, Bjornsson, A, Jonsson, T. Epidemiology of Dupuytren's disease: Clinical, serological, and social assessment. The Reykjavik study. J Clin Epidemiol 2000;53:291–296.CrossRefGoogle ScholarPubMed
Benson, LS, Williams, CS, Kahle, M. Dupuytren's contracture. J Am Acad Orthop Surg 1998;6:24–35.CrossRefGoogle ScholarPubMed
Rayan, GM. Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 2007;89:189–198.CrossRefGoogle ScholarPubMed
Fetsch, JF, Laskin, WB, Miettinen, M. Palmar-plantar fibromatosis in children and preadoleascents: A clinicopathological study of 56 cases with newly recognized demographics and extended follow-up information. Am J Surg Pathol 2005;29: 1095–1105.Google Scholar
Allen, PW. The fibromatoses: a clinicopathologic classification based on 140 cases. Am J Surg Pathol 1977;1:255–270.CrossRefGoogle ScholarPubMed
Ushijima, M, Tsuneyoshi, M, Enjoji, M. Dupuytren type fibromatoses: A clinicopathologic study of 62 cases. Acta Pathol Jpn 1984;34:991–1001.Google ScholarPubMed
Hueston, JT. Some observations on knuckle pads. J Hand Surg [Br] 1984;9:75–78.CrossRefGoogle ScholarPubMed
Aluisio, FV, Mair, SD, Hall, RL. Plantar fibromatosis: treatment of primary and recurrent lesions and factors associated with recurrence. Foot Ankle Int 1996;17:672–678.CrossRefGoogle ScholarPubMed
Zgonis, T, Jolly, GP, Polyzois, V, Kanuck, DM, Stamatis, ED. Plantar fibromatosis. Clin Podiatr Med Surg North Am 2005;22:11–18.CrossRefGoogle ScholarPubMed
Chen, KT, Dyne, DA. Familial plantar fibromatosis. J Surg Oncol 1985;29:240–241.CrossRefGoogle ScholarPubMed
Graells Estrada, J, Garcia Fernandez, D, Badina Tottoella, F, Moreno Carzano, A. Familial plantar fibromatosis. Clin Exp Dermatol 2003;28:669–670.CrossRefGoogle ScholarPubMed
Luck, JV. Dupuytren's contracture: A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959;41:635–664.CrossRefGoogle ScholarPubMed
Evans, HL. Multinucleated giant cell in plantar fibromatosis. Am J Surg Pathol 2002;26:244–248.CrossRefGoogle ScholarPubMed
Palma, L, Santucci, A, Gigante, A, Di Giulio, A, Carloni, S. Plantar fibromatosis: an immunohistochemical and ultrastructural study. Foot Ankle Int 1999;20:253–257.CrossRefGoogle ScholarPubMed
Dal Cin, P, Smet, L, Sciot, R, Damme, B, Berghe, H. Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren's disease. Cancer Genet Cytogenet 1999;108:137–140.CrossRefGoogle ScholarPubMed
Casalone, R, Mazzola, D, Meroni, E, Righi, R, Minelli, E, Granata, P. Cytogenetic and interphase cytogenetic analyses reveal chromosome instability but no clonal trisomy 8 in Dupuytren contracture. Cancer Genet Cytogenet 1997;99:73–76.CrossRefGoogle ScholarPubMed
Wever, I, dal Cin, P, Fletcher, CDM, Mandahl, N, Mertens, F, Mitelman, F. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: A report from the CHAMP study group. Mod Pathol 2000;13:1080–1085.CrossRefGoogle ScholarPubMed
Breiner, JA, Nelson, M, Bredthauer, BD, Neff, JR, Bridge, JA. Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer Genet Cytogenet 1999;108:176–177.Google ScholarPubMed
Sawyer, JR, Sammartino, G, Godden, N, Nicholas, RW. A clonal reciprocal t(2;7)(p13;p13) in plantar fibromatosis. Cancer Genet Cytogenet 2005;158:67–69.CrossRefGoogle Scholar
Chansky, HA, Trumble, TE, Conrad, EU, Wolff, JF, Murray, LW, Raskind, WH. Evidence for a polyclonal etiology of palmar fibromatosis. J Hand Surg 1999;24:339–344.CrossRefGoogle ScholarPubMed
Montgomery, E, Lee, JH, Abraham, SC, Wu, TT. Superficial fibromatosis are genetically distinct from deep fibromatosis. Mod Pathol 2001;14:695–701.CrossRefGoogle Scholar
Bhattacharya, B, Dilworth, HP, Iacobuzio-Donahue, C, Ricci, F, Weber, K, Furlong, MA. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653–659.CrossRefGoogle ScholarPubMed
Sommer, F, Schwarzer, U, Wassmer, G, Block, W, Braun, M, Klotz, T. Epidemiology of Peyronie's disease. Int J Impot Res 2002;14:379–383.CrossRefGoogle ScholarPubMed
Hellstrom, WJ, Bivalaqua, TJ. Peyronie's disease: etiology, medical and surgical therapy. J Androl 2000;21:347–354.Google ScholarPubMed
Smith, BH. Peyronie's disease. Am J Clin Pathol 1966;43:670–678.CrossRefGoogle Scholar
Davis, CJ. The microscopic pathology of Peyronie's disease. J Urol 1997;157:282–284.CrossRefGoogle ScholarPubMed
Ferenc, T, Sygut, J, Kopczynski, J, Mayer, M, Latos-Bielenska, A, Dziki, A. Aggressive fibromatosis (desmoid tumors): Definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol 20006;57:5–15.Google Scholar
Reitamo, JJ, Häyry, P, Nykyri, E, Saxèn, E. The desmoid tumor. I. Incidence, sex-, age and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665–673.CrossRefGoogle ScholarPubMed
Lev, D, Kotilingam, D, Wei, C, Ballo, MT, Zagars, GK, Pisters, PWT. Optimizing treatment of desmoid tumors. J Clin Oncol 2007;25:1785–1791.CrossRefGoogle ScholarPubMed
Fallen, T, Wilson, M, Morlan, B, Lindor, NM. Desmoid tumors – a characterization of patients seen at Mayo clinic 1976–1999. Fam Cancer 2006;5:191–194.CrossRefGoogle Scholar
Heiskanen, I, Järvinen, H. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996;11:157–162.CrossRefGoogle ScholarPubMed
Posner, MC, Shiu, MH, Newsome, JL, Hajdu, SI, Gaynor, JJ, Brennan, MF. The desmoid tumor. Not a benign disease. Arch Surg 1989;124:191–196.CrossRefGoogle Scholar
Brasfield, RD. Das Gupta, TK. Desmoid tumors of the anterior abdominal wall. Surgery 1969;65:241–246.Google ScholarPubMed
Häyry, P, Reitamo, JJ, Totterman, S, Hopfner-Hallikainen, D, Sivula, A. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 1982;77:674–680.CrossRefGoogle ScholarPubMed
Pignatti, G, Barbanti-Brodano, G, Ferrari, D, Gherlinzoni, F, Bertoni, F, Bacchni, P. Extra-abdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000;375:207–213.CrossRefGoogle Scholar
Gronchi, A, Casali, PG, Mariani, L, Lo Vullo, S, Colecchia, M, Lozza, L. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390–1397.CrossRefGoogle Scholar
Merchant, NB, Lewis, JJ, Woodruff, JM, Leung, DH, Brennan, MF. Extremity and trunk desmoid tumors. Cancer 1999;86: 2045–2052.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
Hosalkar, HS, Fox, EJ, Delaney, T, Torbert, JT, Ogilvie, CM, Lackman, RD. Desmoid tumors and current status of management. Orthop Clin North Am 2006;37:53–63.CrossRefGoogle ScholarPubMed
Rock, MG, Pritchard, DJ, Reiman, HM, Soule, EH, Brewster, AR. Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984;66:1369–1374.CrossRefGoogle ScholarPubMed
Abraham, SC, Reynolds, C, Lee, JH, Montgomery, EA, Baisden, BL, Krasinskas, AM, Wu, TT. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 2002;33:39–46.CrossRefGoogle ScholarPubMed
Aaron, AD, O'Mara, JW, Legendre, KE, Evans, SR, Attinger, CE, Montgomery, EA. Chest wall fibromatosis associated with silicone implants. Surg Oncol 1996;5:93–99.CrossRefGoogle Scholar
Burke, AP, Sobin, LH, Shekitka, KM, Federspiel, BH, Helwig, EB. Intara-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990;14:335–341.CrossRefGoogle ScholarPubMed
Sturt, NJH, Clark, SK. Current ideas in desmoid tumors. Fam Cancer 2000;5:275–285.CrossRefGoogle Scholar
Burke, AP, Sobin, LH, Shekitka, KM. Mesenteric fibromatosis: A follow-up study. Arch Pathol Lab Med 1990;114:832–835.Google ScholarPubMed
Mariani, A, Nascimento, AG, Webb, MJ, Sim, FH, Podratz, KC. Surgical management of desmoid tumors of the female pelvis. J Am Coll Surg 2000;191:175–183.CrossRefGoogle ScholarPubMed
Zayid, I, Dihmis, C. Familial multicentric fibromatosis – desmoids. Cancer 1969;24:786–795.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Reis-Filho, JS, Milanezi, F, Pope, ZB, Fillus-Neto, J, Schmitt, FC. Primary fibromatosis of the breast in a patient with multiple desmoid tumors. Pathol Res Pract 2001;197:775–779.CrossRefGoogle Scholar
Biermann, JS. Desmoid tumors. Curr Treat Options Oncol 2000;1:262–262.CrossRefGoogle ScholarPubMed
Heinrich, MC, McArthur, GA, Demetri, GD, Joensuu, H, Bono, P, Herrmann, R. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006;24:1195–1203.CrossRefGoogle Scholar
Enzinger, FM, Shiraki, M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid): analysis of 30 cases followed-up for 10 or more years. Cancer 1967;20:1131–1140.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Ng, TL, Gown, AM, Barry, TS, Cheang, MC, Chan, AK, Turbin, DA. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005;18:68–74.CrossRefGoogle ScholarPubMed
Carlson, JW, Fletcher, CDM. Imunohistochemivsry for ß-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007;51:509–514.CrossRefGoogle Scholar
Saito, T, Oda, Y, Tanaka, K, Matsuda, S, Tamiya, S, Iwamoto, Y. ß-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumors. J Pathol 2001;195:222–228.CrossRefGoogle Scholar
Deyrup, A, Tretiakova, M, Montag, AG. Estrogen receptor-ß expression in extraabdominal fibromatoses: An analysis of 40 cases. Cancer 2006;106:208–213.CrossRefGoogle Scholar
Galiatsatos, P, Foulkes, WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385–398.CrossRefGoogle ScholarPubMed
Okamoto Miyaki, M, Konishi, M, Kikuchi-Yanoshita, R, Enomoto, M, Tanaka, K. Coexistence of somatic and germ-line mutations in APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 1993;53:5079–5082.Google Scholar
Miyaki, M, Konishi, M, Kikuchi-Yanoshita, R, Enomoto, M, Tanaka, K, Takahashi, H. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous plyposis. Cancer Res 1993;53:5079–5082.Google Scholar
Couture, J, Mitri, A, Lagace, R, Smits, R, Berk, T, Bouchard, HL. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 2000;57:205–212.CrossRefGoogle Scholar
Latchford, A, Volikos, E, Johnson, V, Rogers, P, Suraweera, N, Tomlinson, I. APC mutations in FAP-associated desmoid tumours are non-random but not “just right.”Hum Mol Genet 2007;16:78–82.CrossRefGoogle ScholarPubMed
Li, C, Bapat, B, Alman, BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin egulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998;153:709–714.CrossRefGoogle Scholar
Alman, BA, Li, C, Pajerski, ME, Diaz-Cano, S, Wolfe, HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis. Am J Pathol 1997;151:329–334.Google Scholar
Tejpar, S, Nollet, F, Li, C, Wunder, JS, Michils, G, dal Cin, P. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615–6620.CrossRefGoogle Scholar
Miyoshi, Y, Iwao, K, Nawa, G, Ochi, T, Nakamura, Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998;10:591–594.Google ScholarPubMed
Li, M, Cordon-Cardo, C, Gerald, WL, Rosai, J. Desmoid fibromatosis is a clonal process. Hum Pathol 1996;27:939–943.CrossRefGoogle ScholarPubMed
Alman, BA, Pajerski, ME, Diaz-Cano, S, Corboy, K, Wolfe, HJ. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997;6:98–101.CrossRefGoogle Scholar
Lucas, DR, Schroyer, KR, McCarthy, PJ, Markham, NE, Fujita, M, Enomoto, TE. Desmoid tumor is a clonal cellular proliferation: PCR-amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol 1997;21:306–311.CrossRefGoogle ScholarPubMed
Middleton, SB, Frayling, IM, Phillips, RKS. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 2000;82:827–832.CrossRefGoogle ScholarPubMed
Yoshida, MA, Ikeuchi, T, Iwama, T, Miyaki, M, Mori, T, Ushijima, Y. Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis. Jpn J Cancer Res 1991;82:916–921.CrossRefGoogle ScholarPubMed
Dal Cin, P, Sciot, R, Aly, MS, Delabie, J, Stas, M, Wever, I. Some desmoid tumors are characterized by trisomy 8. Genes Chromosomes Cancer 1994;10:131–135.Google ScholarPubMed
Fletcher, JA, Naeem, R, Xiao, S, Corson, JM. Chromosome aberrations in desmoid tumors: Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 1995;79:139–143.CrossRefGoogle Scholar
Mertens, F, Willen, H, Rydholm, A, Brosjo, O, Carlen, B, Mitelman, F. Trisomy 20 is a primary chromosome aberration in desmoid tumors. Int J Cancer 1995;63:527–529.CrossRefGoogle ScholarPubMed
Qi, H, Dal Cin, P, Hernandez, JM, Garcia, JL, Sciot, R, Fletcher, C. Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet 1996;92:147–149.CrossRefGoogle ScholarPubMed
Kouho, H, Aoki, T, Hisaoka, M, Hashimoto, H. Clinicopathological and interphase cytogenetic analysis of desmoid tumors. Histopathology 1997;31:336–341.CrossRefGoogle Scholar
Wever, I, Dal Cin, P, Fletcher, CD, Mandahl, N, Mertens, F, Mitelman, F. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP study group. Mod Pathol 2000;p13;1080–1085.CrossRefGoogle ScholarPubMed
Bridge, JA, Sreekantaiah, C, Mouron, B, Neff, JR, Sandberg, AA, and Wolman, SR. Clonal chromosomal abnormalities in desmoid tumors. Cancer 1992;69:430–436.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Karlsson, I, Mandahl, N, Heim, S, Rydholm, A, Willen, H, Mitelman, F. Complex chromosome rearrangements in an extraabdominal desmoid tumor. Cancer Genet Cytogenet 1988;34:241–245.CrossRefGoogle Scholar
Larramendy, ML, Virolainen, M, Tukiainen, E, Elomaa, I, Knuutila, S. Chromosome band 1q21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer 1998;23:183–186.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
Brandal, P, Micci, F, Bjerkehagen, B, Eknaes, M, Larramendy, M, Lothe, RA, Heim, S. Molecular cytogenetic characterization of desmoid tumors. Cancer Genet Cytogenet 2003;146: 1–7.CrossRefGoogle ScholarPubMed
Ross, DC. Epidemiology of Dupuytren's disease. Hand Clin 1999;15:53–62.Google ScholarPubMed
Gudmundsson, KG, Arngrimsson, R, Sigfusson, N, Bjornsson, A, Jonsson, T. Epidemiology of Dupuytren's disease: Clinical, serological, and social assessment. The Reykjavik study. J Clin Epidemiol 2000;53:291–296.CrossRefGoogle ScholarPubMed
Benson, LS, Williams, CS, Kahle, M. Dupuytren's contracture. J Am Acad Orthop Surg 1998;6:24–35.CrossRefGoogle ScholarPubMed
Rayan, GM. Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 2007;89:189–198.CrossRefGoogle ScholarPubMed
Fetsch, JF, Laskin, WB, Miettinen, M. Palmar-plantar fibromatosis in children and preadoleascents: A clinicopathological study of 56 cases with newly recognized demographics and extended follow-up information. Am J Surg Pathol 2005;29: 1095–1105.Google Scholar
Allen, PW. The fibromatoses: a clinicopathologic classification based on 140 cases. Am J Surg Pathol 1977;1:255–270.CrossRefGoogle ScholarPubMed
Ushijima, M, Tsuneyoshi, M, Enjoji, M. Dupuytren type fibromatoses: A clinicopathologic study of 62 cases. Acta Pathol Jpn 1984;34:991–1001.Google ScholarPubMed
Hueston, JT. Some observations on knuckle pads. J Hand Surg [Br] 1984;9:75–78.CrossRefGoogle ScholarPubMed
Aluisio, FV, Mair, SD, Hall, RL. Plantar fibromatosis: treatment of primary and recurrent lesions and factors associated with recurrence. Foot Ankle Int 1996;17:672–678.CrossRefGoogle ScholarPubMed
Zgonis, T, Jolly, GP, Polyzois, V, Kanuck, DM, Stamatis, ED. Plantar fibromatosis. Clin Podiatr Med Surg North Am 2005;22:11–18.CrossRefGoogle ScholarPubMed
Chen, KT, Dyne, DA. Familial plantar fibromatosis. J Surg Oncol 1985;29:240–241.CrossRefGoogle ScholarPubMed
Graells Estrada, J, Garcia Fernandez, D, Badina Tottoella, F, Moreno Carzano, A. Familial plantar fibromatosis. Clin Exp Dermatol 2003;28:669–670.CrossRefGoogle ScholarPubMed
Luck, JV. Dupuytren's contracture: A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959;41:635–664.CrossRefGoogle ScholarPubMed
Evans, HL. Multinucleated giant cell in plantar fibromatosis. Am J Surg Pathol 2002;26:244–248.CrossRefGoogle ScholarPubMed
Palma, L, Santucci, A, Gigante, A, Di Giulio, A, Carloni, S. Plantar fibromatosis: an immunohistochemical and ultrastructural study. Foot Ankle Int 1999;20:253–257.CrossRefGoogle ScholarPubMed
Dal Cin, P, Smet, L, Sciot, R, Damme, B, Berghe, H. Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren's disease. Cancer Genet Cytogenet 1999;108:137–140.CrossRefGoogle ScholarPubMed
Casalone, R, Mazzola, D, Meroni, E, Righi, R, Minelli, E, Granata, P. Cytogenetic and interphase cytogenetic analyses reveal chromosome instability but no clonal trisomy 8 in Dupuytren contracture. Cancer Genet Cytogenet 1997;99:73–76.CrossRefGoogle ScholarPubMed
Wever, I, dal Cin, P, Fletcher, CDM, Mandahl, N, Mertens, F, Mitelman, F. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: A report from the CHAMP study group. Mod Pathol 2000;13:1080–1085.CrossRefGoogle ScholarPubMed
Breiner, JA, Nelson, M, Bredthauer, BD, Neff, JR, Bridge, JA. Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer Genet Cytogenet 1999;108:176–177.Google ScholarPubMed
Sawyer, JR, Sammartino, G, Godden, N, Nicholas, RW. A clonal reciprocal t(2;7)(p13;p13) in plantar fibromatosis. Cancer Genet Cytogenet 2005;158:67–69.CrossRefGoogle Scholar
Chansky, HA, Trumble, TE, Conrad, EU, Wolff, JF, Murray, LW, Raskind, WH. Evidence for a polyclonal etiology of palmar fibromatosis. J Hand Surg 1999;24:339–344.CrossRefGoogle ScholarPubMed
Montgomery, E, Lee, JH, Abraham, SC, Wu, TT. Superficial fibromatosis are genetically distinct from deep fibromatosis. Mod Pathol 2001;14:695–701.CrossRefGoogle Scholar
Bhattacharya, B, Dilworth, HP, Iacobuzio-Donahue, C, Ricci, F, Weber, K, Furlong, MA. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653–659.CrossRefGoogle ScholarPubMed
Sommer, F, Schwarzer, U, Wassmer, G, Block, W, Braun, M, Klotz, T. Epidemiology of Peyronie's disease. Int J Impot Res 2002;14:379–383.CrossRefGoogle ScholarPubMed
Hellstrom, WJ, Bivalaqua, TJ. Peyronie's disease: etiology, medical and surgical therapy. J Androl 2000;21:347–354.Google ScholarPubMed
Smith, BH. Peyronie's disease. Am J Clin Pathol 1966;43:670–678.CrossRefGoogle Scholar
Davis, CJ. The microscopic pathology of Peyronie's disease. J Urol 1997;157:282–284.CrossRefGoogle ScholarPubMed
Ferenc, T, Sygut, J, Kopczynski, J, Mayer, M, Latos-Bielenska, A, Dziki, A. Aggressive fibromatosis (desmoid tumors): Definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol 20006;57:5–15.Google Scholar
Reitamo, JJ, Häyry, P, Nykyri, E, Saxèn, E. The desmoid tumor. I. Incidence, sex-, age and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665–673.CrossRefGoogle ScholarPubMed
Lev, D, Kotilingam, D, Wei, C, Ballo, MT, Zagars, GK, Pisters, PWT. Optimizing treatment of desmoid tumors. J Clin Oncol 2007;25:1785–1791.CrossRefGoogle ScholarPubMed
Fallen, T, Wilson, M, Morlan, B, Lindor, NM. Desmoid tumors – a characterization of patients seen at Mayo clinic 1976–1999. Fam Cancer 2006;5:191–194.CrossRefGoogle Scholar
Heiskanen, I, Järvinen, H. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996;11:157–162.CrossRefGoogle ScholarPubMed
Posner, MC, Shiu, MH, Newsome, JL, Hajdu, SI, Gaynor, JJ, Brennan, MF. The desmoid tumor. Not a benign disease. Arch Surg 1989;124:191–196.CrossRefGoogle Scholar
Brasfield, RD. Das Gupta, TK. Desmoid tumors of the anterior abdominal wall. Surgery 1969;65:241–246.Google ScholarPubMed
Häyry, P, Reitamo, JJ, Totterman, S, Hopfner-Hallikainen, D, Sivula, A. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 1982;77:674–680.CrossRefGoogle ScholarPubMed
Pignatti, G, Barbanti-Brodano, G, Ferrari, D, Gherlinzoni, F, Bertoni, F, Bacchni, P. Extra-abdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000;375:207–213.CrossRefGoogle Scholar
Gronchi, A, Casali, PG, Mariani, L, Lo Vullo, S, Colecchia, M, Lozza, L. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390–1397.CrossRefGoogle Scholar
Merchant, NB, Lewis, JJ, Woodruff, JM, Leung, DH, Brennan, MF. Extremity and trunk desmoid tumors. Cancer 1999;86: 2045–2052.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
Hosalkar, HS, Fox, EJ, Delaney, T, Torbert, JT, Ogilvie, CM, Lackman, RD. Desmoid tumors and current status of management. Orthop Clin North Am 2006;37:53–63.CrossRefGoogle ScholarPubMed
Rock, MG, Pritchard, DJ, Reiman, HM, Soule, EH, Brewster, AR. Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984;66:1369–1374.CrossRefGoogle ScholarPubMed
Abraham, SC, Reynolds, C, Lee, JH, Montgomery, EA, Baisden, BL, Krasinskas, AM, Wu, TT. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 2002;33:39–46.CrossRefGoogle ScholarPubMed
Aaron, AD, O'Mara, JW, Legendre, KE, Evans, SR, Attinger, CE, Montgomery, EA. Chest wall fibromatosis associated with silicone implants. Surg Oncol 1996;5:93–99.CrossRefGoogle Scholar
Burke, AP, Sobin, LH, Shekitka, KM, Federspiel, BH, Helwig, EB. Intara-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990;14:335–341.CrossRefGoogle ScholarPubMed
Sturt, NJH, Clark, SK. Current ideas in desmoid tumors. Fam Cancer 2000;5:275–285.CrossRefGoogle Scholar
Burke, AP, Sobin, LH, Shekitka, KM. Mesenteric fibromatosis: A follow-up study. Arch Pathol Lab Med 1990;114:832–835.Google ScholarPubMed
Mariani, A, Nascimento, AG, Webb, MJ, Sim, FH, Podratz, KC. Surgical management of desmoid tumors of the female pelvis. J Am Coll Surg 2000;191:175–183.CrossRefGoogle ScholarPubMed
Zayid, I, Dihmis, C. Familial multicentric fibromatosis – desmoids. Cancer 1969;24:786–795.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Reis-Filho, JS, Milanezi, F, Pope, ZB, Fillus-Neto, J, Schmitt, FC. Primary fibromatosis of the breast in a patient with multiple desmoid tumors. Pathol Res Pract 2001;197:775–779.CrossRefGoogle Scholar
Biermann, JS. Desmoid tumors. Curr Treat Options Oncol 2000;1:262–262.CrossRefGoogle ScholarPubMed
Heinrich, MC, McArthur, GA, Demetri, GD, Joensuu, H, Bono, P, Herrmann, R. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006;24:1195–1203.CrossRefGoogle Scholar
Enzinger, FM, Shiraki, M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid): analysis of 30 cases followed-up for 10 or more years. Cancer 1967;20:1131–1140.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Ng, TL, Gown, AM, Barry, TS, Cheang, MC, Chan, AK, Turbin, DA. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005;18:68–74.CrossRefGoogle ScholarPubMed
Carlson, JW, Fletcher, CDM. Imunohistochemivsry for ß-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007;51:509–514.CrossRefGoogle Scholar
Saito, T, Oda, Y, Tanaka, K, Matsuda, S, Tamiya, S, Iwamoto, Y. ß-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumors. J Pathol 2001;195:222–228.CrossRefGoogle Scholar
Deyrup, A, Tretiakova, M, Montag, AG. Estrogen receptor-ß expression in extraabdominal fibromatoses: An analysis of 40 cases. Cancer 2006;106:208–213.CrossRefGoogle Scholar
Galiatsatos, P, Foulkes, WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385–398.CrossRefGoogle ScholarPubMed
Okamoto Miyaki, M, Konishi, M, Kikuchi-Yanoshita, R, Enomoto, M, Tanaka, K. Coexistence of somatic and germ-line mutations in APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 1993;53:5079–5082.Google Scholar
Miyaki, M, Konishi, M, Kikuchi-Yanoshita, R, Enomoto, M, Tanaka, K, Takahashi, H. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous plyposis. Cancer Res 1993;53:5079–5082.Google Scholar
Couture, J, Mitri, A, Lagace, R, Smits, R, Berk, T, Bouchard, HL. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 2000;57:205–212.CrossRefGoogle Scholar
Latchford, A, Volikos, E, Johnson, V, Rogers, P, Suraweera, N, Tomlinson, I. APC mutations in FAP-associated desmoid tumours are non-random but not “just right.”Hum Mol Genet 2007;16:78–82.CrossRefGoogle ScholarPubMed
Li, C, Bapat, B, Alman, BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin egulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998;153:709–714.CrossRefGoogle Scholar
Alman, BA, Li, C, Pajerski, ME, Diaz-Cano, S, Wolfe, HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis. Am J Pathol 1997;151:329–334.Google Scholar
Tejpar, S, Nollet, F, Li, C, Wunder, JS, Michils, G, dal Cin, P. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615–6620.CrossRefGoogle Scholar
Miyoshi, Y, Iwao, K, Nawa, G, Ochi, T, Nakamura, Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998;10:591–594.Google ScholarPubMed
Li, M, Cordon-Cardo, C, Gerald, WL, Rosai, J. Desmoid fibromatosis is a clonal process. Hum Pathol 1996;27:939–943.CrossRefGoogle ScholarPubMed
Alman, BA, Pajerski, ME, Diaz-Cano, S, Corboy, K, Wolfe, HJ. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997;6:98–101.CrossRefGoogle Scholar
Lucas, DR, Schroyer, KR, McCarthy, PJ, Markham, NE, Fujita, M, Enomoto, TE. Desmoid tumor is a clonal cellular proliferation: PCR-amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol 1997;21:306–311.CrossRefGoogle ScholarPubMed
Middleton, SB, Frayling, IM, Phillips, RKS. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 2000;82:827–832.CrossRefGoogle ScholarPubMed
Yoshida, MA, Ikeuchi, T, Iwama, T, Miyaki, M, Mori, T, Ushijima, Y. Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis. Jpn J Cancer Res 1991;82:916–921.CrossRefGoogle ScholarPubMed
Dal Cin, P, Sciot, R, Aly, MS, Delabie, J, Stas, M, Wever, I. Some desmoid tumors are characterized by trisomy 8. Genes Chromosomes Cancer 1994;10:131–135.Google ScholarPubMed
Fletcher, JA, Naeem, R, Xiao, S, Corson, JM. Chromosome aberrations in desmoid tumors: Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 1995;79:139–143.CrossRefGoogle Scholar
Mertens, F, Willen, H, Rydholm, A, Brosjo, O, Carlen, B, Mitelman, F. Trisomy 20 is a primary chromosome aberration in desmoid tumors. Int J Cancer 1995;63:527–529.CrossRefGoogle ScholarPubMed
Qi, H, Dal Cin, P, Hernandez, JM, Garcia, JL, Sciot, R, Fletcher, C. Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet 1996;92:147–149.CrossRefGoogle ScholarPubMed
Kouho, H, Aoki, T, Hisaoka, M, Hashimoto, H. Clinicopathological and interphase cytogenetic analysis of desmoid tumors. Histopathology 1997;31:336–341.CrossRefGoogle Scholar
Wever, I, Dal Cin, P, Fletcher, CD, Mandahl, N, Mertens, F, Mitelman, F. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP study group. Mod Pathol 2000;p13;1080–1085.CrossRefGoogle ScholarPubMed
Bridge, JA, Sreekantaiah, C, Mouron, B, Neff, JR, Sandberg, AA, and Wolman, SR. Clonal chromosomal abnormalities in desmoid tumors. Cancer 1992;69:430–436.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Karlsson, I, Mandahl, N, Heim, S, Rydholm, A, Willen, H, Mitelman, F. Complex chromosome rearrangements in an extraabdominal desmoid tumor. Cancer Genet Cytogenet 1988;34:241–245.CrossRefGoogle Scholar
Larramendy, ML, Virolainen, M, Tukiainen, E, Elomaa, I, Knuutila, S. Chromosome band 1q21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer 1998;23:183–186.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
Brandal, P, Micci, F, Bjerkehagen, B, Eknaes, M, Larramendy, M, Lothe, RA, Heim, S. Molecular cytogenetic characterization of desmoid tumors. Cancer Genet Cytogenet 2003;146: 1–7.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • FIBROMATOSES
  • Edited by Markku Miettinen, Armed Forces Institute of Pathology, Washington DC
  • Book: Modern Soft Tissue Pathology
  • Online publication: 01 March 2011
  • Chapter DOI: https://doi.org/10.1017/CBO9780511781049.009
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • FIBROMATOSES
  • Edited by Markku Miettinen, Armed Forces Institute of Pathology, Washington DC
  • Book: Modern Soft Tissue Pathology
  • Online publication: 01 March 2011
  • Chapter DOI: https://doi.org/10.1017/CBO9780511781049.009
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • FIBROMATOSES
  • Edited by Markku Miettinen, Armed Forces Institute of Pathology, Washington DC
  • Book: Modern Soft Tissue Pathology
  • Online publication: 01 March 2011
  • Chapter DOI: https://doi.org/10.1017/CBO9780511781049.009
Available formats
×